Sabra Health Care REIT, Inc. (SBRA)

Sabra Health Care presents a compelling value story driven by a massive 6% dividend yield and a pivot toward senior housing, yet the market remains skeptical due to a lingering multi-year price decline. The stock has finally broken out of a decade-long downtrend, posting a strong +18% gain last year and continuing to rally recently, which validates the thesis that the demographic tailwind is unstoppable. However, the 190% payout ratio is a glaring red flag; the company is distributing nearly double its earnings, relying entirely on capital recycling to maintain this yield. This makes the dividend unsustainable in its current form, capping the long-term rating at a solid 3 despite the attractive income. Short-term, the technical breakout and analyst upgrades suggest momentum is building, but the defensive options flow warns of potential volatility ahead. Investors should view this as a high-yield turnaround play rather than a pure income vehicle.